"BPA poses no health risk to consumers of any age group at current exposure levels"
"BPA poses no health risk to consumers of any age group at current exposure levels"
"The current Tolerable Daily Intake (TDI) level for BPA is adequately justified."
"An adequate margin of safety exists for BPA at current levels of exposure from food contact uses, for infants and adults"
"The highest estimates for aggregated exposure to BPA from both dietary and non-dietary sources are 3 to 5 times lower than the TDI, depending on the age group."
"An adequate margin of safety exists for BPA at current levels of exposure from food contact uses, for infants and adults"
"Levels of BPA in the human body are very low, indicating that BPA is not accumulated in the body and is rapidly eliminated."
"Studies pursued by FDA's National Center for Toxicological Research (NCTR) have shown no effects of BPA from low-dose exposure"
Previous EFSA assessments
In December 2011, after consideration of a French report on health effects of BPA, EFSA concluded that this does not change the views expressed by the panel in its 2010 opinion on the safety of BPA. No new evidence was found that would lead to revise the current Tolerable Daily Intake (the safe intake level) for BPA of 0.05 mg/kg body weight.
For its 2010 opinion EFSA had reviewed more than 800 new studies including exploratory, non-GLP-studies, and confirmed its earlier position that BPA-based polycarbonate and epoxy food-contact materials are safe for its intended uses.
This followed similar EFSA statements in July and October 2008, and was based on its January 2007 release of a comprehensive scientific assessment of BPA conducted by a panel of independent scientific experts.
In the 2007 review, based on the then available scientific database, EFSA increased five-fold the safe intake level for BPA (TDI). Extensive data from biomonitoring studies show that typical human exposure to BPA from all sources is approximately 1,000 times below the safe intake level set by EFSA.